Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 °C whole body hyperthermia in patients with refractory sarcoma
- 31 May 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (5) , 888-892
- https://doi.org/10.1016/0959-8049(95)00622-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cytokine induction by 41.8 °C whole body hyperthermiaCancer Letters, 1995
- Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8°C whole body hyperthermiaInternational Journal of Hyperthermia, 1995
- A new technological approach to radiant heat whole body hyperthermiaCancer Letters, 1994
- Cytokine Induction in Humans by 41.8 C WholeBody HyperthermiaJNCI Journal of the National Cancer Institute, 1993
- Local hyperthermia enhances cyclophosphamide, ifosfamide andcis-diamminedichloroplatinum cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude miceZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Whole Body Hyperthermia: Biological and Clinical AspectsPublished by Springer Nature ,1992
- Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrowBritish Journal of Cancer, 1991
- Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidineJournal of Neuro-Oncology, 1990
- Thermal enhancement of tetraplatin and carboplatin in human leukaemic cellsInternational Journal of Hyperthermia, 1990